Date published: 2026-1-31

1-800-457-3801

SCBT Portrait Logo
Seach Input

Syk Inhibitor IV, BAY 61-3606 HCl (CAS 732983-37-8)

5.0(1)
Write a reviewAsk a question

See product citations (25)

Alternate Names:
BAY 61-3606; 2-(7-(3,4-Dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino)-nicotinamide HCl
Application:
Syk Inhibitor IV, BAY 61-3606 HCl is an imidazopyrimidine inhibitor of Syk and Syk-mediated functions
CAS Number:
732983-37-8
Purity:
≥97%
Molecular Weight:
426.86
Molecular Formula:
C20H18N6O3•HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Syk Inhibitor IV, BAY 61-3606 HCl, is a chemical compound engineered to selectively block the activity of spleen tyrosine kinase (Syk), a enzyme in the signaling pathways of immune cells. The incorporation of hydrochloride (HCl) enhances its stability and solubility, rendering it more suitable for research purposes. This inhibitor is extensively used in the fields of immunology and oncology for experimental investigations. It plays a vital role in examining Syk kinase′s involvement in immune cell signaling, aiding in the understanding of inflammation, immune cell engagement, and the mechanics of antibody responses. Furthermore, its utility extends to oncology research, where its capacity to impede Syk′s role in cell growth and survival is being assessed for its potential to obstruct tumor development. The efficacy of Syk Inhibitor IV, BAY 61-3606 HCl lies in its targeted disruption of the ATP-binding site on Syk kinase, thereby halting the enzyme′s ability to phosphorylate target substrates and affecting signaling pathways in immune activation and possibly in cancer cell proliferation.


Syk Inhibitor IV, BAY 61-3606 HCl (CAS 732983-37-8) References

  1. The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents.  |  Yamamoto, N., et al. 2003. J Pharmacol Exp Ther. 306: 1174-81. PMID: 12766258
  2. High glucose-induced NF-kappaB activation occurs via tyrosine phosphorylation of IkappaBalpha in human glomerular endothelial cells: involvement of Syk tyrosine kinase.  |  Yang, WS., et al. 2008. Am J Physiol Renal Physiol. 294: F1065-75. PMID: 18353872
  3. Dectin-1/Syk signaling is involved in Lactobacillus casei cell wall extract-induced mouse model of Kawasaki disease.  |  Lin, IC., et al. 2013. Immunobiology. 218: 201-12. PMID: 22633994
  4. Vascular endothelial growth factor-a in lactobacillus casei cell wall extract-induced coronary arteritis of a murine model.  |  Lin, IC., et al. 2014. Circ J. 78: 752-62. PMID: 24334707
  5. Keyhole limpet hemocyanin induces innate immunity via Syk and Erk phosphorylation.  |  Yasuda, K. and Ushio, H. 2016. EXCLI J. 15: 474-481. PMID: 27822175
  6. A spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cells.  |  Seo, HH., et al. 2017. Biol Res. 50: 1. PMID: 28100269
  7. Development of Novel Cell Lines for High-Throughput Screening to Detect Estrogen-Related Receptor Alpha Modulators.  |  Teng, CT., et al. 2017. SLAS Discov. 22: 720-731. PMID: 28346099
  8. A phosphatidylinositol 4,5-bisphosphate redistribution-based sensing mechanism initiates a phagocytosis programing.  |  Mu, L., et al. 2018. Nat Commun. 9: 4259. PMID: 30323235

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Syk Inhibitor IV, BAY 61-3606 HCl, 2 mg

sc-202351
2 mg
$327.00